A more aggressive FTC is starting to target drug mergers and industry middlemen

Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by President Donald Trump.

Related Keywords

Switzerland ,Illinois ,United States ,Ireland ,California ,San Francisco ,Americans ,Amgen Repatha ,Lina Khan ,Robin Feldman ,Bristol Myers Squibb Celgene ,Dave Ricks ,David Balto ,Aaron Glick ,Us District Court ,Zinc Health Services ,University Of California College The Law ,Amgen ,Ascent Health Services ,Department Of Justice ,Allergan ,Testimony In Congress ,Eli Lilly Co ,Emisar Pharma Services ,Cowen Co ,Federalist Society ,Federal Trade Commission ,Horizon Therapeutics ,Chair Lina Khan ,California College ,Myers Squibb Celgene ,Zinc Health ,John Kness ,President Donald Trump ,Express Scripts ,Eli Lilly ,